{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:02:16Z","timestamp":1790258536255,"version":"4.1.0"},"reference-count":15,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.3201\/eid2004.131536","type":"journal-article","created":{"date-parts":[[2014,3,3]],"date-time":"2014-03-03T16:56:37Z","timestamp":1393865797000},"page":"705-708","source":"Crossref","is-referenced-by-count":58,"title":["<i>Salmonella<\/i>Subtypes with Increased MICs for Azithromycin in Travelers Returned to the Netherlands"],"prefix":"10.3201","volume":"20","author":[{"given":"Robert-Jan","family":"Hassing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wil H.F.","family":"Goessens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfrid","family":"van Pelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dik J.","family":"Mevius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno H.","family":"Stricker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicky","family":"Molhoek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelies","family":"Verbon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perry J.J.","family":"van Genderen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2004.131536-201403171443-R1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11908-004-0021-6","article-title":"Typhoid fever.","volume":"6","author":"Parry","year":"2004","journal-title":"Curr Infect Dis Rep"},{"key":"key-10.3201\/eid2004.131536-201403171443-R2","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1128\/AAC.49.5.1775-1781.2005","article-title":"Application of an in vitro infection model and simulation for reevaluation of fluoroquinolone breakpoints for Salmonella enterica serotype typhi.","volume":"49","author":"Booker","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2004.131536-201403171443-R3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/j.1469-0691.2011.03703.x","article-title":"EUCAST expert rules in antimicrobial susceptibility testing.","volume":"19","author":"Leclercq","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"key-10.3201\/eid2004.131536-201403171443-R4","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1128\/AAC.37.5.1203","article-title":"In vitro activity of azithromycin against bacterial enteric pathogens.","volume":"37","author":"Gordillo","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2004.131536-201403171443-R5","doi-asserted-by":"crossref","unstructured":"Metchock B. In-vitro activity of azithromycin compared with other macrolides and oral antibiotics againstSalmonellatyphi. J Antimicrob Chemother. 1990;25 Suppl A:29\u201331.","DOI":"10.1093\/jac\/25.suppl_A.29"},{"key":"key-10.3201\/eid2004.131536-201403171443-R6","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/jac\/44.2.243","article-title":"Treatment of typhoid fever with azithromycin versus chloramphenicol in a randomized multicentre trial in India.","volume":"44","author":"Butler","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid2004.131536-201403171443-R7","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1128\/AAC.00447-06","article-title":"Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever.","volume":"51","author":"Parry","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2004.131536-201403171443-R8","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1128\/AAC.43.6.1441","article-title":"Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance.","volume":"43","author":"Girgis","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2004.131536-201403171443-R9","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1128\/AAC.44.7.1855-1859.2000","article-title":"A randomized controlled comparison of azithromycin and ofloxacin for treatment of multidrug-resistant or nalidixic acid-resistant enteric fever.","volume":"44","author":"Chinh","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2004.131536-201403171443-R10","doi-asserted-by":"publisher","first-page":"e2188","DOI":"10.1371\/journal.pone.0002188","article-title":"A multi-center randomised controlled trial of gatifloxacin versus azithromycin for the treatment of uncomplicated typhoid fever in children and adults in Vietnam.","volume":"3","author":"Dolecek","year":"2008","journal-title":"PLoS ONE"},{"key":"key-10.3201\/eid2004.131536-201403171443-R11","doi-asserted-by":"publisher","first-page":"3985","DOI":"10.1128\/AAC.00590-11","article-title":"Antimicrobial susceptibility to azithromycin among Salmonella enterica isolates from the United States.","volume":"55","author":"Sj\u00f6lund-Karlsson","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2004.131536-201403171443-R12","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1099\/jmm.0.47353-0","article-title":"In vitro activity of azithromycin, newer quinolones and cephalosporins in ciprofloxacin-resistant Salmonella causing enteric fever.","volume":"56","author":"Capoor","year":"2007","journal-title":"J Med Microbiol"},{"key":"key-10.3201\/eid2004.131536-201403171443-R13","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4103\/0255-0857.93017","article-title":"Rationale of azithromycin prescribing practices for enteric fever in India.","volume":"30","author":"Rai","year":"2012","journal-title":"Indian J Med Microbiol"},{"key":"key-10.3201\/eid2004.131536-201403171443-R14","doi-asserted-by":"publisher","first-page":"4655","DOI":"10.1128\/JCM.00648-10","article-title":"First report of Salmonella enterica serotype paratyphi A azithromycin resistance leading to treatment failure.","volume":"48","author":"Molloy","year":"2010","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid2004.131536-201403171443-R15","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1007\/s10096-013-1878-9","article-title":"Decreased ciprofloxacin susceptibility in Salmonella Typhi and Paratyphi infections in ill-returned travellers: the impact on clinical outcome and future treatment options.","volume":"32","author":"Hassing","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/20\/4\/13-1536_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T04:25:50Z","timestamp":1733286350000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/20\/4\/13-1536_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2004.131536","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}